[JANX] QoQ Quarter Result on 31-Mar-2021 [#Q1]

Stock
[JANX] Janux Therapeutics, Inc.
Announcement Date
30-Mar-2021
Financial Year
2021
Quarter
31-Mar-2021 [#Q1]
Profit Trend
QoQ- -38.01%
YoY- -61.64%
Quarter Report
JANX's Result
JANX's Financial Summary
View:
Show?
Quarter Result
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Revenue 1,616 1,159 482 380 0 0 0 -
PBT -13,416 -10,766 -6,206 -2,284 -1,655 -1,256 -2,460 208.87%
Tax -74 137 46 0 0 0 -1,136 -83.72%
NP -13,416 -10,766 -6,206 -2,284 -1,655 -1,256 -2,460 208.87%
Tax Rate - - - - - - - -
Total Cost 15,032 11,925 6,688 2,664 1,655 1,256 2,460 233.13%
Ratio Analysis
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
NP Margin -830.20 -928.90 -1,287.55 -601.05 0.00 0.00 0.00 -
Per Share
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
EPS -0.33 -0.26 -0.62 -0.06 -0.13 -0.10 -0.20 39.50%
EPS Diluted -0.33 -0.26 -0.62 -0.06 -0.13 -0.10 -0.20 39.50%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.